Free shipping on all orders over $ 500

Siguazodan

Cat. No. M27861

All AbMole products are for research use only, cannot be used for human consumption.

Siguazodan Structure
Synonym:

SKF 94836

Price and Availability

For this product's availability, delivery time and price, please email inquiry@abmole.com directly or click the "Inquiry Now" button below.


Quality Control & Documentation
Biological Activity

Siguazodan (SKF 94836) is a potent, selective and orally active phosphodiesterase III (PDE-III) inhibitor with an IC50 of 117 nM. Siguazodan increases cAMP accumulation in intact platelets with an EC50 of 18.88 μM. Siguazodan also inhibits phenylephrine-induced 5-HT release with an IC50 value of 4.2 μM.

Chemical Information
Molecular Weight 284.32
Formula C14H16N6O
CAS Number 115344-47-3
Form Solid
Solubility (25°C) DMSO 12.5 mg/mL (ultrasonic and warming and heat to 60°C)
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] C K Billington, et al. Am J Physiol. Modulation of human airway smooth muscle proliferation by type 3 phosphodiesterase inhibition

[2] Y Qian, et al. Br J Pharmacol. Effects of rolipram and siguazodan on the human isolated bronchus and their interaction with isoprenaline and sodium nitroprusside

[3] D C Underwood, et al. J Pharmacol Exp Ther. Comparison of phosphodiesterase III, IV and dual III/IV inhibitors on bronchospasm and pulmonary eosinophil influx in guinea pigs

[4] N C Turner, et al. Br J Pharmacol. Relaxation of guinea-pig trachea by cyclic AMP phosphodiesterase inhibitors and their enhancement by sodium nitroprusside

[5] K J Murray, et al. Br J Pharmacol. The effects of siguazodan, a selective phosphodiesterase inhibitor, on human platelet function

Related PDE Products
GSK256066

GSK256066 is a selective phosphodiesterase 4 (PDE4)inhibitor with an IC50 of 3.2 pM. *The compound is unstable in solutions, freshly prepared is recommended

BAY-60-7550

BAY-60-7550 is a potent PDE2 inhibitor with IC50 values of 2.0 nM (bovine) and 4.7 nM (human).

Roflumilast

Roflumilast (APTA-2217; BYK 20869; B9302-107) is a novel and selective, long-acting inhibitor of phosphodiesterase 4 (PDE-4).

Piclamilast

Piclamilast (RP 73401) is a potent and selective inhibitor of phosphodiesterase (PDE) 4.

Apremilast

Apremilast is a novel, orally available small molecule inhibitor of PDE4 with IC50 of 74 nM. Apremilast inhibits TNF-α release by lipopolysaccharide (LPS) with an IC50 of 104 nM.

  Catalog
Abmole Inhibitor Catalog




Keywords: Siguazodan, SKF 94836 supplier, PDE, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.